Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1055/A-2591-5502 | ||||
| Año | 2025 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Obstructive sleep apnea (OSA) is a widespread condition associated with an elevated risk of adverse outcomes. Continuous positive airway pressure (CPAP) is the gold standard treatment, particularly for moderate to severe OSA. However, in many instances, CPAP compliance falls short of expectations, necessitating physicians to consider additional interventions to alleviate patient symptoms. A comprehensive understanding of OSA endotypes and phenotypes can potentially enhance the confidence in selecting the appropriate combination or intervention to improve patient care. In this review, we will discuss various interventions and medications available to enhance the treatment of patients with OSA, following a precision medicine approach.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Labarca, Gonzalo | - |
Pontificia Universidad Católica de Chile - Chile
Mayo Clin - Estados Unidos Mayo Clinic in Jacksonville, Florida - Estados Unidos |
| 2 | Henriquez-Beltran, Mario | Hombre |
Hosp Univ Arnau Vilanova St Maria - España
Inst Hlth Carlos III - España Universidad Adventista de Chile - Chile Universidad Santo Tomás - Chile Hospital Universitari Arnau de Vilanova de Lleida - España Centro de Investigación Biomédica en Red de Enfermedades Respiratorias - España |
| 3 | Solomons, Daniel | - |
Pontificia Universidad Católica de Chile - Chile
|
| Fuente |
|---|
| National Institute of Health |
| ResMed Foundation |
| Sleep Research Society |
| American Academy of Sleep Medicine |
| CHEST Foundation |
| Agencia Nacionalde Investigacion y Desarrollo (ANID, Chile, Fondecyt) |
| Agradecimiento |
|---|
| There was no specific funding for the current investigation. G.L. declares grant support from the National Institute of Health and the American Academy of Sleep Medicine, The Chest Foundation; The Sleep Research Society, The ResMed Foundation, and Agencia Nacionalde Investigacion y Desarrollo (ANID, Chile, Fondecyt#11240972) |